A randomized, controlled trial of parenteral glutamine in ill, very low birth-weight neonates

Journal of Pediatric Gastroenterology and Nutrition

Volumn 37, Issue 5, 2003, Pages 550-553

  Thompson, Sam W ^a   McClure, B G ^b   Tubman, T R J ^b  

^a CRAIGAVON AREA HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Glutamine; Parenteral nutrition; Preterm

Indexed keywords

AMINO ACID; AMMONIA; GLUTAMIC ACID; GLUTAMINE; LACTIC ACID; LEUCINE; METHIONINE; PHENYLALANINE; PYRUVIC ACID; VALINE; UREA;

AMINO ACID BLOOD LEVEL; AMMONIA BLOOD LEVEL; ARTICLE; BLOOD CULTURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ENTERIC FEEDING; FEMALE; GESTATIONAL AGE; HUMAN; LACTATE BLOOD LEVEL; LEUKOCYTE COUNT; LEUKOCYTE DIFFERENTIAL COUNT; MALE; NEWBORN; NEWBORN SEPSIS; NUTRITIONAL SUPPORT; OUTCOMES RESEARCH; PARENTERAL NUTRITION; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SUPPLEMENTATION; UREA NITROGEN BLOOD LEVEL; VERY LOW BIRTH WEIGHT; BIRTH WEIGHT; BLOOD; INFANT NUTRITION; LIVER FUNCTION TEST; RISK FACTOR; TIME;

AMINO ACIDS; AMMONIA; BIRTH WEIGHT; ENTERAL NUTRITION; FEMALE; GESTATIONAL AGE; GLUTAMINE; HUMANS; INFANT NUTRITION PHYSIOLOGY; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; LACTIC ACID; LIVER FUNCTION TESTS; MALE; PARENTERAL NUTRITION; PYRUVIC ACID; RISK FACTORS; TIME FACTORS; UREA;

EID: 1542599161     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-200311000-00008     Document Type: Article

References (15)

1. Rennie JM. Perinatal management at the lower margin of viability. Arch Dis Child Fetal Neonatal Ed 1996;74:F214-8.
2. Wilson DC, McClure BG, Halliday HL, et al. Nutrition and bronchopulmonary dysplasia. Arch Dis Child 1991;66:37-8.
3. Hughes CA, Dowling RH. Speed of onset of adaptive mucosal hypoplasia and hypofunction in the intestine of parenterally fed rats. Clin Sci 1980;59:317-27.
4. Chandra RK. Nutrition as a critical determinant in susceptibility to infection. World Rev Nutr Diet 1976;25:166-88.
5. Bergstrom J, Furst P, Noree LO, et al. Intracellular free aminoacid concentrations in human muscle tissue. J Appl Physiol 1974;36: 693-7.
6. Lacey J, Wilmore DW. Is glutamine a conditionally essential aminoacid? Nutr Rev 1990;48:297-309.
7. Van der Hulst RWJ, Van Kreel BK, Von Meyenfeldt MF, et al. Glutamine and preservation of gut integrity. Lancet 1993;341: 1363-5.
8. Hinshaw DB, Burger JM. Protective effect of glutamine on endothelial cell ATP in oxidant injury. J Surg Res 1990;49:222-7.
9. Alverdy JA, Aoys E, WeissCarrington, et al. The effect of glutamine-enriched TPN on gut immune cellularity. J Surg Res 1992;52:34-8.
10. Ziegler TR, Benfell K, Smith RJ, et al. Safety and metabolic effects of L-glutamine administration on humans. J Parenteral Enteral Nutr 1990;14:137S-45S.
11. Ziegler TR, Benfell K, Smith RJ, et al. Metabolism of oral and IV glutamine in healthy humans. Fed Proc 1989;3:A1248.
12. Lowe DK, Benfell K, Smith RJ, et al. The safety of glutamine enriched parenteral nutrient solutions in humans. Am J Clin Nutr 1990;52:1101-1106
13. Lacey JM, Crouch JB, Benfell K, et al. The effects of glutamine-supplemented parenteral nutrition in premature infants. J Parenter Enteral Nutr 1996;20(1):74-80.
14. Neu J, Roig J, Meetze W, et al. Enteral glutamine supplementation for very low birth weight infants decreases morbidity. J Pediatr 1997;131(5):691-9.
15. Poindexter BB, Ehrenkranz R, Stoll B, et al. Parenteral glutamine supplementation in ELBW infants: a multicenter randomized clinical trial [abstract 1847]. Proceedings of the Pediatric Academic Societies Annual Meeting, Baltimore, Maryland, May 4-7, 2002.